Valuation: Philogen S.p.A.

Market Cap 833M 929M 768M 697M 1.32B 87.1B 1.36B 9.19B 3.66B 46.67B 3.49B 3.41B 148B P/E 2026 *
-26.5x
P/E 2027 * -41.5x
Enterprise Value 620M 692M 572M 519M 982M 64.84B 1.01B 6.84B 2.73B 34.74B 2.6B 2.54B 110B EV / Sales 2026 *
7.81x
EV / Sales 2027 * 14x
Free-Float
26.38%
Yield 2026 *
3.48%
Yield 2027 * 1.69%
1 day-2.59%
1 week+0.49%
1 month-5.91%
3 months-13.93%
6 months-2.82%
Current year-11.16%
1 week 20.6
Extreme 20.6
21.5
1 month 20.35
Extreme 20.35
22.05
Current year 19.56
Extreme 19.56
26
1 year 19.56
Extreme 19.56
26
3 years 16.3
Extreme 16.3
27.8
5 years 13
Extreme 13
27.8
10 years 12.6
Extreme 12.6
27.8
Manager TitleAgeSince
Chief Executive Officer 63 04/10/2020
Chief Executive Officer 63 31/12/1995
Director of Finance/CFO 55 -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 57 31/12/1995
Director/Board Member 63 31/12/1995
Date Insider Type Main position Quantity % Market Cap. Importance
05/02/26 Sell

Director

800 0.0027%
28/05/24 Buy

Director

10,000 0.0342%
25/01/22 Buy

Director

3,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-2.59%+0.49%-14.46%+11.59% 958M
+0.01%+11.10%+60.83%+70.43% 68.22B
+1.22%+9.56%+15.97%+90.23% 59.82B
+0.24%+1.35%+23.78%+97.55% 56.07B
+1.60%+19.44%+28.80%+112.95% 47.67B
-1.32%+4.78%+29.15%+40.40% 45.95B
-3.54%-0.60%+207.76%+879.50% 43.29B
-3.33%+6.90%+22.78%+48.07% 35.66B
-2.19%-3.71%+90.94%+66.33% 34.73B
-2.54%+0.08%+45.49%-0.90% 25.6B
Average -1.24%+5.54%+51.10%+141.61% 42B
Weighted average by Cap. -0.75%+5.71%+55.66%+155.49%

Financials

2026 *2027 *
Net sales 79.41M 88.54M 73.18M 66.46M 126M 8.3B 129M 876M 349M 4.45B 332M 325M 14.06B 42.6M 47.5M 39.26M 35.65M 67.48M 4.45B 69.36M 470M 187M 2.39B 178M 174M 7.54B
Net income -32M -35.68M -29.49M -26.78M -50.69M -3.35B -52.1M -353M -141M -1.79B -134M -131M -5.67B -20.03M -22.34M -18.46M -16.77M -31.73M -2.09B -32.62M -221M -88.08M -1.12B -83.84M -82.06M -3.55B
Net Debt -213M -237M -196M -178M -337M -22.26B -347M -2.35B -936M -11.93B -891M -872M -37.7B -238M -265M -219M -199M -377M -24.89B -388M -2.63B -1.05B -13.34B -996M -975M -42.16B
Projected Income Statement - Annual - Philogen S.p.A.
Logo Philogen S.p.A.
Philogen SpA is an Italy-based company, operating in the biotechnology sector. The Company develops products and technologies for the diagnosis and therapy of serious human diseases. It has three anti-cancer antibody derivatives, produced with an in-house industrial process, into Phase I/II clinical studies. The majority of its technologies and products are based on high-affinity human monoclonal antibody fragments. Philogen SpA developed a patented technology, Iterative Colony Filter Screening, for the isolation of monoclonal antibodies, which requires neither immunization nor phage display. The Company's subsidiaries are Philotec, Philomed and Philochem. Philogen SpA is headquartered in Siena, Italy.
Employees
230
Date Price Change Volume
10/11/26 €20.70 -2.59% 16,167
09/11/26 €21.25 +0.47% 11,884
06/11/26 €21.15 +2.67% 3,480
05/11/26 €20.60 -1.44% 14,399
04/11/26 €20.90 +1.46% 8,381
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Philogen S.p.A.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
20.70EUR
Average target price
28.33EUR
Spread / Average Target
+36.88%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Philogen S.p.A.
  1. Stock Market
  2. Stocks
  3. PHIL Stock